Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing crohn's disease

Digestive Diseases and Sciences

Volumn 54, Issue 8, 2009, Pages 1746-1752

  Tougeron, David ^a   Savoye, Guillaume ^a   Savoye Collet, Céline ^a   Koning, Edith ^a   Michot, Francis ^a   Lerebours, Eric ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Infliximab; MR imaging; Perianal Crohn's disease

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METRONIDAZOLE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ABSCESS DRAINAGE; ADULT; ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROHN DISEASE; ENTEROPATHY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAINTENANCE THERAPY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIANAL FISTULIZING CROHN DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROCTITIS; RECTOSCOPY; REMISSION; TISSUE REPAIR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINA DISEASE; DRUG COMBINATION; INTESTINE FISTULA; MIDDLE AGED; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; WOUND DRAINAGE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CIPROFLOXACIN; CROHN DISEASE; DRAINAGE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL FISTULA; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; METRONIDAZOLE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 67649951542     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0545-y     Document Type: Article

References (29)

1. L Beaugerie P Seksik I Nion-Larmurier JP Gendre J Cosnes 2006 Predictors of Crohn's disease Gastroenterology 130 650 656 10.1053/j.gastro.2005.12.019
2. C Gower-Rousseau JL Salomez JL Dupas R Marti MC Nuttens A Votte 1994 Incidence of inflammatory bowel disease in northern France (1988-1990) Gut 35 1433 1438 10.1136/gut.35.10.1433 (Pubitemid 24310907)
3. F Molinie C Gower-Rousseau T Yzet V Merle B Grandbastien R Marti 2004 Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999) Gut 53 843 848 10.1136/gut.2003.025346
4. B Singh C Mc NJ Mortensen DP Jewell B George 2004 Perianal Crohn's disease Br J Surg 91 801 814 10.1002/bjs.4613
5. DH Present P Rutgeerts S Targan SB Hanauer L Mayer RA van Hogezand 1999 Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1398 1405 10.1056/NEJM199905063401804
6. BE Sands FH Anderson CN Bernstein WY Chey BG Feagan RN Fedorak 2004 Infliximab maintenance therapy for fistulizing Crohn's disease N Engl J Med 350 876 885 10.1056/NEJMoa030815
7. A Ouraghi S Nieuviarts JL Mougenel M Allez M Barthet F Carbonnel 2001 Infliximab therapy for Crohn's disease anoperineal lesions Gastroenterol Clin Biol 25 949 956 (Pubitemid 33151809)
8. G Lichtenstein S Yan M Bala M Blank BE Sands 2005 Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease Gastroenterology 128 862 869 10.1053/j.gastro.2005.01.048
9. RL West CJ van der Woude BE Hansen RJF Felt-Bersma AJP van Tilburg JAG Drapers 2004 Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study Aliment Pharmacol Ther 20 1329 1336 10.1111/j.1365-2036.2004.02247.x
10. SA Hyder S Travis D Jewell N Mortensen B George 2006 Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment Dis Colon Rectum 49 1837 1841 10.1007/s10350-006-0656-5
11. DA Schwartz CR Herdman 2004 Review article: the medical treatment of Crohn's perianal fistulas Aliment Pharmacol Ther 19 953 967 10.1111/j.1365-2036. 2004.01917.x
12. T Ochsenkuhn B Goke M Sackmann 2002 Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease Am J Gastroenterol 97 2022 2025 (Pubitemid 34906851)
13. O Schroder A Blumenstein A Schulte-Bockholt J Stein 2004 Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine Aliment Pharmacol Ther 19 295 301 10.1111/j.1365-2036.2004.01850.x
14. J Markowitz J Rosa K Grancher H Aiges F Daum 1990 Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease Gastroenterology 90 1347 1351 (Pubitemid 20381869)
15. DC Pearson GR May GH Fick LR Sutherland 1995 Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis Ann Intern Med 123 132 142
16. DR Topstad R Panaccione JA Heine DRE Johnson AR MacLean WD Buie 2003 Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease. A single center experience Dis Colon Rectum 46 577 583 10.1007/s10350-004-6611-4
17. JG Williams DA Rothenberger FD Nemer SM Goldberg 1991 Fistula-in ano in Crohn's disease. Results of aggressive surgical treatment Dis Colon Rectum 34 378 384 10.1007/BF02053687
18. S Ardizzone G Maconi E Colombo MG Bollani Sand G Bianchi Porro 2004 Perianal fistulae following infliximab treatment. Clinical and endosonographic outcome Inflamm Bowel Dis 10 91 96 10.1097/00054725-200403000-00005
19. G Van Assche D Vanbeckevoort D Bielen G Coremans I Aerden M Noman 2003 Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease Am J Gastroenterol 98 332 339 (Pubitemid 36232382)
20. EV Loftus 2004 Editorial imaging and therapy for perianal Crohn's disease: on the right track? Am J Gastroenterol 99 89 90 10.1111/j.1572-0241. 2004.04016.x
21. MA Parsi JP Achkar S Richardson J Katz JP Hammel BA Lashner 2002 Predictors of response to infliximab in patients with Crohn's disease Gastroenterology 123 707 713 10.1053/gast.2002.35390
22. MA Parsi BA Lashner JP Achkar JT Connor A Brzezinski 2004 Type of fistula determines responses to infliximab in patients with fistulous Crohn's disease Am J Gastroenterol 99 445 449 10.1111/j.1572-0241.2004.04083.x
23. S Vermeire E Louis A Carbonez G Van Assche M Noman J Belaiche 2002 Demographic and clinical parameters influencing the short-term outcome of anti-TNF necrosis factor (infliximab) treatment on Crohn's disease Am J Gastroenterol 97 2357 2363 10.1111/j.1572-0241.2002.05991.x (Pubitemid 35052055)
24. M Regueiro H Mardini 2003 Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to examine under anaesthesia with seton placement Inflamm Bowel Dis 9 98 103 10.1097/00054725-200303000-00003
25. I Rasul SR Wilson H MacRae S Irwin GR Greenberg 2004 Clinical and radiological responses after infliximab treatment for perianal fistulising Crohn's disease Am J Gastroenterol 99 82 88 10.1046/j.1572-0241.2003.04009.x
26. SJ Bell AC Halligan ACJ Windsor AB Williams P Wiesel MA Kamm 2003 Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance Aliment Pharmacol Ther 17 387 393 10.1046/j.1365-2036.2003. 01427.x
27. DA Schwartz CM White PE Wise AJ Herline 2005 Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas Inflamm Bowel Dis 11 727 732 10.1097/01.MIB.0000172811.57242. 18
28. P Rutgeerts RH Diamonds M Bala A Olson GR Lichtenstein W Bao 2006 Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointest Endosc 63 433 442 10.1016/j.gie.2005.08.011
29. P Rutgeerts S Vermeire G Van Assche 2007 Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 56 453 455 10.1136/gut.2005.088732